Showing results (11-20 of 73) with videos related to
Sort By:
Pageof 8
Seminars in Hematology|May 1, 2022
Cell senescence and malignant transformation in the inherited bone marrow failure syndromes: Overlapping pathophysiology with therapeutic implicationsEmma M Groarke, Rodrigo T Calado, Johnson M LiuSeminars in Hematology|November 22, 2021
Thrombotic manifestations of VEXAS syndromeEmma M Groarke, Alina E Dulau-Florea, Yogendra KanthiNature Communications|May 20, 2025
In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndromeHiroki Mizumaki, Shouguo Gao, Zhijie Wu, et al.Annals of Hematology|August 21, 2024
Role of allogeneic hematopoietic cell transplantation in VEXAS syndromeAjoy L Dias, Emma M Groarke, Dennis Hickstein, et al.Haematologica|January 8, 2026
Telomere attrition is common in patients with germline <i>RUNX1</i> pathogenic variantsRialnat A Lawal, Fernanda Gutierrez-Rodrigues, David J Young, et al.Best Practice & Research. Clinical Haematology|August 18, 2021
Somatic mosaicism in inherited bone marrow failure syndromesFernanda Gutierrez-Rodrigues, Sushree S Sahoo, Marcin W Wlodarski, et al.British Journal of Haematology|January 14, 2026
Hypomethylating agents in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS): A systematic reviewFieke W Hoff, Roochi Trikha, Emma M Groarke, et al.Blood|June 25, 2025
Clinical and molecular features of immunodeficiency in patients with telomere biology disordersLuiz Fernando Bazzo Catto, Nidhi Aggarwal, Ruba Shalhoub, et al.Seminars in Hematology|November 22, 2021
Toward a pathophysiology inspired treatment of VEXAS syndromeMaël Heiblig, Bhavisha A Patel, Emma M Groarke, et al.Leukemia|July 27, 2022
Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemiaEmma M Groarke, Bhavisha A Patel, Ruba Shalhoub, et al.Pageof 8